Abstract:Background: This study has evaluated urinary tract injuries and dysfunction after Radical Hysterectomy (RH) performed in patients with cervical cancer and has compared the cystometric parameters and urinary complications occurring in these patients with those occurring in patients who had undergone Simple Hysterectomy (SH).
“…Surgery in the form of radical hysterectomy has its own set of complications such as reduced/absent bladder sensation and ureteric fistulae (and the same has been adequately explored by researchers. 3,4 Both Constipation and urinary dysfunction have been reported in earlier studies due to injury to the parasympathetic nerves during pelvic surgery. 3,[6][7] Women with cervical cancer frequently develop symptoms like hematuria and/or overactive bladder resulting from various causes including cystitis due to both direct and indirect effects of cancer and its treatments.…”
Section: Introductionmentioning
confidence: 97%
“…3,4 Both Constipation and urinary dysfunction have been reported in earlier studies due to injury to the parasympathetic nerves during pelvic surgery. 3,[6][7] Women with cervical cancer frequently develop symptoms like hematuria and/or overactive bladder resulting from various causes including cystitis due to both direct and indirect effects of cancer and its treatments. The major syndromes encountered in these women are increased susceptibility to infections due to both physical and immunologic effects of treatment, haemorrhagic cystitis caused by chemotherapeutic urothelial toxins and urinary problems caused by both acute and chronic effects of radiation therapy.…”
Section: Introductionmentioning
confidence: 97%
“…[4][5][6][7] Chemotherapy has widespread effects on various systems and specifically to lower urinary tract, can be a cause of haemorrhagic cystitis. [2][3][4] While assessing the need for specialist urogynaecological input in our patients, we noticed that contemporary literature available on morbidity burden of urinary symptoms is restricted only to very few specific conditions/complications. Surgery in the form of radical hysterectomy has its own set of complications such as reduced/absent bladder sensation and ureteric fistulae (and the same has been adequately explored by researchers.…”
Section: Introductionmentioning
confidence: 99%
“…Cystitis is seen usually as radiation doses approach 3000 cGy to the bladder. [1][2][3][4][5][6] This presents as accompanied by suprapubic tenderness, dysuria, urinary frequency and urgency Incontinence. As doses to the bladder approach more than 6000 cGy, acute hemorrhagic cystitis, chronic cystitis, fibrosis with decreased bladder capacity, and fistula formation may ensue.…”
Section: Introductionmentioning
confidence: 99%
“…As doses to the bladder approach more than 6000 cGy, acute hemorrhagic cystitis, chronic cystitis, fibrosis with decreased bladder capacity, and fistula formation may ensue. [1][2][3][4][5][6] The treatment of urinary incontinence in patients with prior radiation exposure and history of radical hysterectomy is particularly complicated especially for continuous incontinence of extraurethral origin viz fistula as surgical treatments can be compromised by the poor vascular supply to the tissues after radiation therapy. [4][5][6][7] Chemotherapy has widespread effects on various systems and specifically to lower urinary tract, can be a cause of haemorrhagic cystitis.…”
Background: A lot of research has focussed on bowel symptoms but data is relatively scarce on exact burden of urinary subset of urogynaecological symptoms in survivors of cervical cancer. Aims and objectives: To find out the prevalence of urinary subset of urogynaecological symptoms, in women with advanced cervical carcinoma treated with surgery and/or radiotherapy and comparing same with a control group. Methods: A questionnaire incorporating demographic and urogynaecological (urinary) symptoms (IUGA terminology) was prepared and used to interview over 400 women between October 2008 and June 2010 in a case control observational design; 200 patients (study group) with history of treated cervical cancer, attending gynaecological cancer clinic and 200 patients (control group) with benign conditions attending Gynaecology outpatient clinic were interviewed. The frequency of various urinary problems was correlated with the demographic data and cystoscopic findings wherever appropriate and available. Results: Increased daytime frequency of urination (25% vs. 6%, p=0.0001), dysuria (25% vs. 3%, p= 0.0001) and hematuria (26% vs. 2%, p= 0.0001) were seen more in cervical cancer patients compared to the controls. Nocturia (30% vs. 6%, p=0.6) and urinary hesitancy (7% vs. 2%, p=0.09) did not show any statistically significant difference. Among urinary incontinence, 'any' urinary incontinence (38% vs. 3%, p=0.0001), urge incontinence was seen in 1% vs. 3 %, stress incontinence in 28% vs. 8%, p=0.0001, "continuous (extra urethral origin)" incontinence was seen in 8% vs. 0% and "mixed" incontinence in 1% vs. 2% (all cancer versus control group). Conclusions: There is a high burden of urogynaecological problems in women with carcinoma cervix treated with surgery and/or chemo-radiotherapy as compared to controls.
“…Surgery in the form of radical hysterectomy has its own set of complications such as reduced/absent bladder sensation and ureteric fistulae (and the same has been adequately explored by researchers. 3,4 Both Constipation and urinary dysfunction have been reported in earlier studies due to injury to the parasympathetic nerves during pelvic surgery. 3,[6][7] Women with cervical cancer frequently develop symptoms like hematuria and/or overactive bladder resulting from various causes including cystitis due to both direct and indirect effects of cancer and its treatments.…”
Section: Introductionmentioning
confidence: 97%
“…3,4 Both Constipation and urinary dysfunction have been reported in earlier studies due to injury to the parasympathetic nerves during pelvic surgery. 3,[6][7] Women with cervical cancer frequently develop symptoms like hematuria and/or overactive bladder resulting from various causes including cystitis due to both direct and indirect effects of cancer and its treatments. The major syndromes encountered in these women are increased susceptibility to infections due to both physical and immunologic effects of treatment, haemorrhagic cystitis caused by chemotherapeutic urothelial toxins and urinary problems caused by both acute and chronic effects of radiation therapy.…”
Section: Introductionmentioning
confidence: 97%
“…[4][5][6][7] Chemotherapy has widespread effects on various systems and specifically to lower urinary tract, can be a cause of haemorrhagic cystitis. [2][3][4] While assessing the need for specialist urogynaecological input in our patients, we noticed that contemporary literature available on morbidity burden of urinary symptoms is restricted only to very few specific conditions/complications. Surgery in the form of radical hysterectomy has its own set of complications such as reduced/absent bladder sensation and ureteric fistulae (and the same has been adequately explored by researchers.…”
Section: Introductionmentioning
confidence: 99%
“…Cystitis is seen usually as radiation doses approach 3000 cGy to the bladder. [1][2][3][4][5][6] This presents as accompanied by suprapubic tenderness, dysuria, urinary frequency and urgency Incontinence. As doses to the bladder approach more than 6000 cGy, acute hemorrhagic cystitis, chronic cystitis, fibrosis with decreased bladder capacity, and fistula formation may ensue.…”
Section: Introductionmentioning
confidence: 99%
“…As doses to the bladder approach more than 6000 cGy, acute hemorrhagic cystitis, chronic cystitis, fibrosis with decreased bladder capacity, and fistula formation may ensue. [1][2][3][4][5][6] The treatment of urinary incontinence in patients with prior radiation exposure and history of radical hysterectomy is particularly complicated especially for continuous incontinence of extraurethral origin viz fistula as surgical treatments can be compromised by the poor vascular supply to the tissues after radiation therapy. [4][5][6][7] Chemotherapy has widespread effects on various systems and specifically to lower urinary tract, can be a cause of haemorrhagic cystitis.…”
Background: A lot of research has focussed on bowel symptoms but data is relatively scarce on exact burden of urinary subset of urogynaecological symptoms in survivors of cervical cancer. Aims and objectives: To find out the prevalence of urinary subset of urogynaecological symptoms, in women with advanced cervical carcinoma treated with surgery and/or radiotherapy and comparing same with a control group. Methods: A questionnaire incorporating demographic and urogynaecological (urinary) symptoms (IUGA terminology) was prepared and used to interview over 400 women between October 2008 and June 2010 in a case control observational design; 200 patients (study group) with history of treated cervical cancer, attending gynaecological cancer clinic and 200 patients (control group) with benign conditions attending Gynaecology outpatient clinic were interviewed. The frequency of various urinary problems was correlated with the demographic data and cystoscopic findings wherever appropriate and available. Results: Increased daytime frequency of urination (25% vs. 6%, p=0.0001), dysuria (25% vs. 3%, p= 0.0001) and hematuria (26% vs. 2%, p= 0.0001) were seen more in cervical cancer patients compared to the controls. Nocturia (30% vs. 6%, p=0.6) and urinary hesitancy (7% vs. 2%, p=0.09) did not show any statistically significant difference. Among urinary incontinence, 'any' urinary incontinence (38% vs. 3%, p=0.0001), urge incontinence was seen in 1% vs. 3 %, stress incontinence in 28% vs. 8%, p=0.0001, "continuous (extra urethral origin)" incontinence was seen in 8% vs. 0% and "mixed" incontinence in 1% vs. 2% (all cancer versus control group). Conclusions: There is a high burden of urogynaecological problems in women with carcinoma cervix treated with surgery and/or chemo-radiotherapy as compared to controls.
Background To describe a technique of vaginal robot-assisted radical hysterectomy (VRARH) that utilizes the advantages of a robotic system and eliminates the manipulation of cancer tissue.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.